Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

JAMA Network... · 21:12 · 1,355 plays

From the album JAMA Neurology Author Interviews

Description

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD. Related Content: Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder

More By JAMA Network...

1
AlbumJAMA Neurology Author Interviews
JAMA Network... · 3,909 plays
2
Acoustic Analysis of Primary Care Patient–Clinician Conversations to Screen for Cognitive Impairment
JAMA Network... · 5,149 plays · 22:39
3
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome
JAMA Network... · 2,795 plays · 14:18
4
Epstein-Barr Virus Antibodies and Multiple Sclerosis
JAMA Network... · 3,131 plays · 14:58
5
Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage
JAMA Network... · 1,845 plays · 15:56
6
US Burden of Disorders Affecting the Nervous System
JAMA Network... · 3,733 plays · 23:32
7
Smoking, Exhaled Carbon Monoxide, and Risk of Parkinson Disease
JAMA Network... · 3,935 plays · 19:27
8
Phenoconversion in Pure Autonomic Failure
JAMA Network... · 975 plays · 24:00
9
Direct-Acting OACs and Antiseizure Medications for AF and Epilepsy and Risk of Thromboembolic Events
JAMA Network... · 1,889 plays · 19:31
10
Early Pregnancy Use of Anti-CGRP Monoclonal Antibodies and Propranolol and Spontaneous Abortion Risk
JAMA Network... · 2,957 plays · 22:32

You May Also Like